|
|
|
40
|
4331AB
|
SUTENT 12.5MG TAB (PFI/STO) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
3,453.88
|
123.35
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331AB
|
SUTENT 12.5MG TAB (PFI) SUNITINIB (BQ)
|
SUNITINIB
|
SUTENT
|
28'S
|
BQ
|
3453.88
|
123.3527
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331AB
|
SUTENT 12.5MG CAP (PFI) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
3,453.88
|
123.35
|
TAB
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4331AC
|
SUTENT 25MG TAB (PFI/STO) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
6,792.60
|
242.59
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331AC
|
SUTENT 25MG TAB (PFI) SUNITINIB (BQ)
|
SUNITINIB
|
SUTENT
|
28'S
|
BQ
|
6792.6
|
242.5929
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331AC
|
SUTENT 25MG CAP (PFI) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
6,792.60
|
242.59
|
TAB
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4331E
|
SUTENT 50MG TAB (PFI/STO) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
12,664.1
|
452.29
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331E
|
SUTENT 50MG TAB (PFI) SUNITINIB (BQ)
|
SUNITINIB
|
SUTENT
|
28'S
|
BQ
|
12664.16
|
452.2913
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331E
|
SUTENT 50MG CAP (PFI) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
12,664.16
|
452.29
|
TAB
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|